Lipid bilayer composition influences small multidrug transporters by Charalambous, Kalypso et al.
 
 
 
BIROn - Birkbeck Institutional Research Online 
 
Enabling open access to Birkbeck’s published research output 
 
 
 
Lipid bilayer composition influences small multidrug 
transporters 
 
Journal Article 
 
http://eprints.bbk.ac.uk/4772 
 
 
Version: Published (Refereed) 
 
Citation: 
 
 
 
 
 
 
 
 
 
© 2008 The author(s) 
 
 
 
Publisher version 
 
 
______________________________________________________________ 
 
All articles available through Birkbeck ePrints are protected by intellectual property law, including 
copyright law. Any use made of the contents should comply with the relevant law. 
______________________________________________________________ 
 
Deposit Guide 
 
Contact: lib-eprints@bbk.ac.uk 
Birkbeck ePrints 
Charalambous, K.; Miller, D.; Curnow, P.; Booth, P.J. (2008) 
Lipid bilayer composition influences small multidrug transporters –  
BMC Biochemistry 9(31) 
BioMed CentralBMC Biochemistry
ssOpen AcceResearch article
Lipid bilayer composition influences small multidrug transporters
Kalypso Charalambous1, David Miller2, Paul Curnow2 and Paula J Booth*2
Address: 1Department of Crystallography, Birkbeck College, University of London, London WC1E 7HX, UK and 2Department of Biochemistry, 
University of Bristol, Bristol BS8 1TD, UK
Email: Kalypso Charalambous - k.charalambous@mail.cryst.bbk.ac.uk; David Miller - david.miller@bristol.ac.uk; 
Paul Curnow - p.curnow@bristol.ac.uk; Paula J Booth* - paula.booth@bristol.ac.uk
* Corresponding author    
Abstract
Background: Membrane proteins are influenced by their surrounding lipids. We investigate the
effect of bilayer composition on the membrane transport activity of two members of the small
multidrug resistance family; the Escherichia coli transporter, EmrE and the Mycobacterium
tuberculosis, TBsmr. In particular we address the influence of phosphatidylethanolamine and anionic
lipids on the activity of these multidrug transporters. Phosphatidylethanolamine lipids are native to
the membranes of both transporters and also alter the lateral pressure profile of a lipid bilayer.
Lipid bilayer lateral pressures affect membrane protein insertion, folding and activity and have been
shown to influence reconstitution, topology and activity of membrane transport proteins.
Results: Both EmrE and TBsmr are found to exhibit a similar dependence on lipid composition,
with phosphatidylethanolamine increasing methyl viologen transport. Anionic lipids also increase
transport for both EmrE and TBsmr, with the proteins showing a preference for their most
prevalent native anionic lipid headgroup; phosphatidylglycerol for EmrE and phosphatidylinositol for
TBsmr.
Conclusion: These findings show that the physical state of the membrane modifies drug transport
and that substrate translocation is dependent on in vitro lipid composition. Multidrug transport
activity seems to respond to alterations in the lateral forces exerted upon the transport proteins
by the bilayer.
Background
Multidrug membrane transport proteins are very effective
in antibiotic resistance as they pump drugs across bacte-
rial membranes and out of cells. The family of small
multidrug (SMR) transporters are the smallest known
multidrug transport proteins [1], consisting of 4 trans-
membrane α helices [2-4]. The mechanism of multidrug
transport is not understood in detail and SMR proteins
provide an opportunity to probe the process in greater
depth. Lipid composition and global properties of the
lipid bilayer play key roles in membranes, often actively
modifying the function of membrane proteins. Multidrug
transporters themselves bind a variety of substrates and
thus, flexibility in the transport protein binding pocket
may be reflected in sensitivity to their surrounding lipids.
In particular the proteins are likely to be sensitive to glo-
bal lipid bilayer properties and the forces exerted on them
by their surrounding lipids. Here, we investigate SMR pro-
teins from two common pathogens; EmrE from
Escherichia coli (E. coli)and TBsmr from Mycobacterium
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BMC Biochemistry 2008, 9:31 http://www.biomedcentral.com/1471-2091/9/31tuberculosis (M. tuberculosis). We focus on the influence of
lipid bilayer composition on SMR protein function.
SMR proteins are proton, drug antiporters and extrude a
variety of hydrophobic, cationic substrates through an
exchange of the substrate and proton at a Glu residue (E14
for EmrE) [5]. Substrate binding and transport is thus pH
dependent as it is affected by the protonation state of this
Glu residue, the pKA of which has been estimated as 8.5 for
E14 in EmrE [6]. EmrE confers resistance to a variety of
molecules, including ethidium, methylviologen (MV),
tetraphenylphosphonium (TPP) and tetracycline. TBsmr
has 41% sequence identity to EmrE and transports ethid-
ium and MV, but cannot transport TPP [7]. EmrE is the
best characterised family member and seems to function
as a dimer [4,8-13].
EmrE is found in the bacterial inner membrane of gram
negative E. coli, the major constituents of which are phos-
phatidylethanolamine (PE) lipids, followed by anionic
phosphatidylglycerol (PG) with a smaller proportion of
cardiolipin. M. tuberculosis are classified as acid fast bacte-
ria, as the high mycolic acid content of their cell walls is
responsible for their resistance to acids that are used dur-
ing staining procedures and results in poor staining com-
pared to gram negative or positive bacteria. Despite
differences between the cell walls of E. Coli and M. tuber-
culosis, TBsmr of the latter bacteria also resides in a mem-
brane dominated by PE lipids, but the second major lipid
constituent is anionic phosphatidylinositol (PI) lipid and
then cardiolipin [14,15]. Here, we investigate the influ-
ence of lipid composition on MV transport by EmrE in
defined lipid-bilayer vesicles with a PC background. Dio-
leoyl PC lipids with C18 chains each with one unsaturated
bond (DOPC) form fluid lamellar bilayers, while the cor-
responding DOPE lipid alone forms non-lamellar phases
as it induces monolayer curvature towards the aqueous
phase. Increasing the proportion of DOPE increases the
curvature elastic stress of the bilayer, which is also accom-
panied by an increase in the lipid chain lateral pressure
[16-18]. These effects have been shown to affect the inser-
tion, folding and function of membrane proteins [19-24].
In addition, we have previously shown that the DOPE
content of DOPC/DOPE bilayers affects the activity of
EmrE [25]. This reflects PE altering the overall properties
and lateral pressure profile of the bilayer. We also found
preliminary evidence for a role of the anionic lipid PG in
enhancing activity. Here, we extend our work and investi-
gate the effects of PE and PG on the activity of EmrE and
TBsmr. In such a systematic study of lipid effects, we use
synthetic lipids with defined chains as opposed to the
native lipids, which for example in the case of E. Coli PE
are a mixture of different chain lengths and saturation.
EmrE and TBsmr can be reconstituted into E. coli lipid ves-
icles and transport MV, but TBsmr transports less well
than EmrE. We measure substrate transport in different
lipid conditions. Optimisation of an established radioac-
tive assay [8,26,27] enables us to compare the lipid influ-
ence on MV transport by the two transporters with
different native lipid composition; EmrE from gram nega-
tive E. coli and TBsmr from acid-fast M. tuberculosis.
Results
MV transport
EmrE and TBsmr were purified into n-dodecyl-β-d-malto-
side (DDM), as His-tagged protein following overexpres-
sion in E. coli according to previous methods [7]. Protein
yields were ~1 mg for EmrE and 2.5 mg of TBsmr per litre
of culture at > 95% purity.
Reconstitution and assay conditions were optimised using
EmrE and E. coli lipid vesicles. Transport activity was
quantified using pH driven transport of radiolabelled,
14C, MV a method that has been extensively applied to
EmrE [8]. Previous reconstitution procedures [28] were
optimised to maintain a pH gradient across the liposome
bilayer during the transport measurement. EmrE was puri-
fied into DDM, but was then exchanged into octyl-β-D-
glucopyranoside (OG) prior to reconstitution into lipid
vesicles. Although EmrE is less stable in OG, this detergent
is easier to remove from the bilayer than DDM (following
reconstitution into lipid vesicles) as OG has a higher crit-
ical micelle concentration (CMC) than DDM (0.53% or
18 mM for OG as opposed to 0.009% or 0.17 mM for
DDM). Thus this initial exchange of the protein to OG
reduces proton leakage through the lipid bilayer enabling
a proton gradient to be maintained which can drive MV
translocation over minutes. The amount of OG remaining
after reconstitution into E. coli lipid vesicles was 0.3 mM
(well below the CMC of 18 mM and leaving a lipid:OG
ratio 430:1). If EmrE was reconstituted directly from
DDM into lipid vesicles (i.e. omitting the initial transfer to
OG), 0.09% (1.8 mM) of DDM remained in E. coli pro-
tein-containing lipid vesicles. This is above the CMC of
0.009% and resulted in leaky lipid vesicles that could not
maintain a pH gradient. The OG reconstitution procedure
used here also involved only partial pre-saturation of the
lipid vesicles by OG to help maintain bilayer integrity, but
which also meant that <50% of the protein reconstituted.
For example, 50 μg of EmrE was initially mixed with E. coli
lipid vesicles but only 21 μg were found to be associated
with the vesicles after reconstitution. Since SMR proteins
are more unstable in OG compared to DDM, the proteins
were immediately reconstituted into lipid vesicles follow-
ing detergent exchange into OG.
EmrE was reconstituted, via OG, into E. coli lipid vesicles
that were initially prepared by sonication or extrustion to
give differing sizes (50 and 200 nm in diameter). As
shown in figure 1 increased assay reproducibility is
observed when vesicles were formed by extrusion ratherPage 2 of 12
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were chosen over 200 nm lipid vesicles, since it was possi-
ble to determine both a linear regime of transport to deter-
mine an "initial rate of transport" as well as saturation of
transport (by loss of pH gradient or substrate accumula-
tion). The initial rate of MV transport by EmrE in 50 nm
E. coli lipid vesicles was ~250 nmol. min-1. mg-1.
In summary, reconstitution of OG solubilised SMR pro-
teins in OG pre-saturated lipid vesicles, gave tight lipid
vesicles with low proton leakage and enabled linear MV
transport to be observed in lipid vesicles over several min-
utes and thus initial rates to be determined. Radiolabelled
MV transport provides a quantitative measure of EmrE
transport activity. Activities over specified range of lipid
conditions were quantified for EmrE and TBsmr by MV
transport, as MV is a substrate for both proteins.
Lipid dependence of EmrE and TBsmr by MV transport
MV transport by EmrE was investigated in lipid vesicles of
PC/PE, PC/PG and PG/PE. As an example, figure 2a shows
raw data for pH-driven transport of MV into PC/PG lipid
vesicles containing EmrE. We investigated maintenance of
the proton gradient in the different lipid vesicles using a
pH sensitive dye. Proton leakage has previously been
shown to be unaffected by changes in membrane proper-
ties such as fluidity and lateral pressure induced by PE
[29] and has been found to be particularly low in PE and
anionic lipid containing membranes [30,31]. Figure 2b
shows there was very little change in the fluorescence of
the pH sensitive dye, carboxyfluorescein, enclosed within
EmrE-containing lipid vesicles. The pH gradient was well
maintained in all synthetic lipid mixtures during the time
period (~10 mins) over which MV transport was linear
with time. Good maintenance of the pH gradient (i.e. <
5% change in dye fluorescence) was observed over 60
mins for all PC/PE, PC/PG and PG/PE EmrE-containing
lipid vesicles used here (EmrE being incorporated exactly
as for the transport assays), apart from 100% DOPC lipid
vesicles. A larger increase of about 25% over 60 mins (but
still only ~6% over the 10 mins transport rate measure-
ment period) was observed in DOPC lipid vesicles con-
taining EmrE. This indicates a small, continual reduction
in the pH gradient across these vesicles thus MV transport
is probably slightly underestimated in this particular lipid
composition. The initial fluorescence intensity of 10 μM
carboxyfluorescein within the EmrE-lipid vesicles of all
PC, PG and PE compositions varied by <15% (see figure
2b for two examples; PC/PG and PC/PE), indicating that
the magnitude of the pH gradients was similar in all lipid
compositions. A higher fluorescence intensity (see figure
2b) was however observed for E. coli lipid vesicles contain-
ing EmrE together with a gradual, non-linear increase in
the fluorescence of ~30% over 10 mins, showing the pH
gradient is poorly maintained in E. coli lipids. Despite this
reduction of pH gradient, E. coli lipids showed higher
rates of transport (~20-fold greater than in DOPC), thus
still indicating an effect of lipid composition on transport
activity.
In order to compare transport over a range of lipid com-
positions, the initial rates (obtained from the linear
region of a graph such as figure 2a) were determined per
mg of EmrE associated with the lipid vesicles. The protein
concentrations used in the assays were quantified using
Western blots following colorimetric detection. The
amount of protein associated with the lipid vesicles was
found to be independent of lipid composition. In order to
eliminate variations in initial rates due to different protein
preparations, the same thawed protein sample was used
for comparisons of rates across each lipid series; for exam-
ple, a protein sample was exchanged from DDM into OG,
and aliquots of this one sample used for all PC/PG meas-
urements. We also only compare relative increases in ini-
tial rates for the same protein sample.
Figure 2c shows the initial rate of MV transport increases,
when increasing amounts of PE or PG are incorporated in
DOPC lipid vesicles. The initial rates per mg EmrE are
plotted relative to the rate in DOPC, with the actual initial
MV transport by EmrEFigu e 1
MV transport by EmrE. Radiolabelled, 14C MV2+ transport 
into E. coli lipid vesicles by EmrE over time. EmrE reconsti-
tuted into E. coli lipid vesicles extruded to (n), 50 nm; (m), 
200 nm and (s), sonicated lipid vesicles. Control data is 
shown for (h), absence of a pH gradient and (r), absence of 
protein in 50 nm lipid vesicles. Errors are shown as first 
standard deviation of 3 measurements on different protein 
preparations (with each value used for each protein prepara-
tion, for each data point shown, also being the average of 3 
measurements on that particular preparation).Page 3 of 12
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(a) 14C MV2+ transport by EmrE into vesicles of a defined mixture of lipids; DOPC/DOPG with 0.7 mole fraction DOPGFigure 2
(a) 14C MV2+transport by EmrE into vesicles of a defined mixture of lipids; DOPC/DOPG with 0.7 mole fraction 
DOPG. Data are raw transport data, not corrected for the amount of protein associated with the lipid vesicles. (b) Fluores-
cence intensity over time of the pH sensitive dye, carboxyfluorescein, incorporated inside lipid vesicles, illustrating the mainte-
nance of the pH gradient over time in protein-containing vesicles of varying lipid composition: E. coli lipids (upper dark grey 
trace); DOPC/DOPG with 0.7 mole fraction DOPG (middle black trace) and DOPC/DOPE lipid vesicles with 0.4 mole fraction 
DOPE (lower light grey trace). The fluorescence intensities in the lower two traces only increase by ~5% over 60 mins, which 
is within the noise of the data. A ~30% increase in fluorescence intensity occurs in the upper E. coli trace over 60 mins (~9% 
over 10 mins). (c) Initial rate of 14C MV2+ transported by EmrE as a function of lipid composition in DOPC lipid vesicles. (h), 
DOPC/DOPE (t), DOPC/DOPG. These initial rates are determined from the linear region of the MV transport data and addi-
tionally corrected for the amount of protein associated with the lipid vesicles. Thus, the point (t) at 0.7 for DOPC/DOPG is 
determined from figure 2a. Data points are joined for clarification. (d) Initial rate of 14C MV2+ transported by EmrE as a func-
tion of DOPE mole fraction in DOPG/DOPE lipid vesicles. All assays were carried out with 42 μM 14C MV2+. Data in figures 2c 
and d are initial rate data, corrected for the amount of protein, thus are per mg of EmrE. For comparison, they are shown rel-
ative to the rate in DOPC lipid vesicles in (b) or the rate in DOPG in (c) (i.e. with the relative rate for DOPC or DOPG being 
1). Data in (a) are the average of for triplicate measurements for one protein sample (see methods), with the errors being 
smaller than the data points. Data in b and c are determined by linear fits to the initial rate data, as for example in (a); the 
errors from these fits are also smaller than the data points.
A
B
C
D
BMC Biochemistry 2008, 9:31 http://www.biomedcentral.com/1471-2091/9/31rate values being given in table 1. Figure 2c shows there is
an abrupt increase with PG at around 0.4 mole fraction
PG and with a mole fraction of 0.7 the rate is ~22-fold
greater in PC/PG lipid vesicles than in PC alone. The ini-
tial MV rate also increases with PE, in PC/PE with an
apparent maximum rate at about 0.4 mole fraction PE in
PC/PE, which is about 25-fold greater than the rate in
DOPC. At higher PE mole fractions (~0.6–0.7) there may
be some phase separation of PE. Figure 2d shows that
there is also an increase in MV rate as the PE content of
PG/PE lipid vesicles is increased (rates shown relative to
that in DOPG). PG/PE represents the most favourable
environment in terms of initial MV transport rate: there is
a 7-fold increase in rate over DOPG alone, when 0.7 mole
fraction of PE is present, which in addition to the fact that
the rate in DOPG is ~6 times that in DOPC, means that
PG/0.7 PE gives over 40-fold enhancement in MV rate
over DOPC alone (see table 1). The effect of PG on MV
transport is not a straightforward, additive effect of the PC
and PG mixtures but seems to be more complex, since
larger rates are noted for PC/PG mixtures than in either PC
or PG alone. Thus, the initial rate of MV transport
increases to a maximum in PC/PG with 0.7 mole fraction
PG, where it is ~22-fold greater than in DOPC. The rate
enhancement in DOPG is however, less than this, being
only ~6-fold greater than in DOPC.
TBsmr was less active than EmrE in the lipids used here
thus the amount of protein and the pH gradient were
increased by raising the pH from 8 to 9 outside the lipid
vesicles (and keeping the interior pH at 7.5). Figure 3a
shows that linear transport was observed over longer
times than for the EmrE experiments, but that less MV was
incorporated into the lipid vesicles even with the larger
pH gradient (cf figure 1). The rate of MV transport by
TBsmr was ~50 nmol. min-1. mg-1 in E. coli lipids (with pH
9 outside the lipid vesicles), which is approximately 5 fold
slower than that of EmrE of ~250 nmol. min-1. mg-1 (with
pH 8 outside). MV transport by TBsmr was investigated in
the same PC, PE and PG lipid systems as for EmrE. Addi-
tionally since the native TBsmr membrane contains PI (as
opposed to PG) transport in DOPC/Soy PI and Soy PI/
DOPE lipid vesicles was also investigated. Figure 3b and
table 1 show that the rate of MV transport by TBsmr
increased with increasing PE or PG in PC lipid vesicles,
with a maximum at about 0.4 mole fraction PE, similarly
to EmrE (see figure 2c) but the overall increase is only
about 4-fold, and lower than that for EmrE. This smaller
dependence on lipid composition also masked any effect
of PE in PG/PE lipid vesicles (see table 1). A larger increase
in TBsmr activity was seen with increasing PI in PC/PI
lipid vesicles, for which there was a maximum transport
rate at about 0.4–0.5 mole fraction PI that was about 20-
fold greater than the rate in DOPC (3c). The addition of
PE to the anionic PI caused ~5-fold increase in PI/0.6 PE
over DOPG or ~25-fold increase over DOPC (see figure
3c).
In summary, the activity of both EmrE and TBsmr increase
with PE or anionic lipid, with the native PI lipid increas-
ing the rate more than PG for TBsmr. The addition of
DOPE to DOPC bilayers has the same effect on EmrE and
TBsmr initial rates of transport. An increase in activity,
which maximizes at 40% DOPE is observed followed by a
gradual decrease above this DOPE percentage. In addition
the largest increase in TBsmr activity is observed upon the
incorporation of PI to DOPC lipids, a phenomenon mir-
rored upon the addition of DOPG to DOPC with respect
to EmrE activity. Finally the largest initial rates are seen for
PG/PE or PI/PE mixtures, respectively for EmrE or TBsmr.
Table 1: Initial rate of 14C MV2+ transported by EmrE and TBsmr as a function of lipid composition
EmrE
Initial rate of 14C MV2+ transport (nmol. 
min-1. mg-1)
TBsmr
Initial rate of 14C MV2+ transport (nmol. min-1. mg-1)
Mole frac-
tion of 
added lipida
DOPC/
DOPE
(PE added to 
PC)
DOPC/
DOPG
(PG added 
to PC)
DOPG/
DOPE
(PE added to 
PG)
DOPC/
DOPE
(PE added to 
PC)
DOPC/
DOPG
(PG added 
to PC)
DOPG/
DOPE
(PE added to 
PG)
DOPC/SoyPI
(PI added to 
PG)
SoyPI/DOPE
(PE added to 
PI)
0 14 14 81 13 13 58 13 53
0.1 32 7 135 7 7 23 45 ND
0.2 62 67 95 7 22 49 50 86
0.3 213 18 149 12 18 26 43 ND
0.4 349 291 138 55 30 26 261 316
0.5 235 286 301 44 30 29 251 ND
0.6 76 292 409 22 59 47 104 331
0.7 179 315 577 33 28 39 94 ND
a The mole fraction is that of the second lipid; for DOPC/DOPE it refers to the mole fraction the DOPE that is addedPage 5 of 12
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MV transport by TBsmrFigu e 3
MV transport by TBsmr. (a) 14C MV2+ transport into (n) 50 nm extruded E. coli lipid vesicles over time; control data with 
(h) no TBsmr present; (r), no pH gradient. Initial rate of 14C MV transport as a function of lipid composition into (b) (h), 
DOPC/DOPE; (t), DOPC/DOPG and (c) (s) DOPC/soyPI; (m), soyPI/DOPE (the second lipid in each case is the mole frac-
tion on the x axis). Data points are joined to clarify trends. Data in figures 3b and 3c are initial rate data, corrected for the 
amount of protein (thus are per mg of TBsmr) and shown relative to the rate in DOPC lipid vesicles. There is a larger pH gra-
dient than for EmrE (pH 9 on the outside of the liposome for TBsmr, but pH 8 for EmrE and pH 7 inside for both proteins). As 
for EmrE, 42 μM 14C MV2+ was used in the TBsmr measurements.
A
B
C
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Km and Vmax were estimated for MV transport by EmrE in
the different lipid mixtures. Figure 4 shows the depend-
ence of the EmrE initial transport rate on MV concentra-
tion in DOPC, which in a simple, Michaelis Menten
model would saturate at some point; when all proteins are
transporting. However, the curves did not saturate fully
even at very high MV concentrations, >2 mM (and simi-
larly for PC/PG mixtures; non specific MV binding being
subtracted at each MV concentration in all cases). Such a
high 2 mM concentration of MV corresponds to about 1
MV molecule per lipid and since the positive charges and
overall polarity of MV means it can bind to phospholipid
headgroups [32], MV will bind and significantly interfere
with the liposome structure and lipid bilayer properties at
this 1:1 ratio. Thus, the bilayer properties will be gradually
altered as the MV concentration increases and at high MV
concentrations will be significantly different to those of
MV-free lipid vesicles. Since, bilayer composition and
properties influences transport activity by EmrE, this
means the bilayer itself is changing and is no longer inert
during these MV measurements. The background, non-
specific binding (or partitioning) of MV to the lipid vesi-
cles increased with MV concentration, being ~30 times
greater at 600 μM MV than at 42 μM MV. However, the
background binding did not change over time at any MV
concentration and thus does not represent passive diffu-
sion of MV across the bilayer (data not shown).
The non-specific binding/partitioning of MV was found to
depend on lipid composition. Twice as much MV parti-
tioning was observed in 100% DOPG than in 100%
DOPC (data not shown). The higher partitioning of MV
into DOPG vesicles is most likely due to the negative
charge of DOPG lipids attracting the positively charged
MV. This effect could also partly explain the greater trans-
port of MV into DOPG lipid vesicles by EmrE, since there
will be a higher local concentration of MV present at the
membrane surface or partitioned into the membrane.
However, there must also be an additional effect, other
than charge, since the highest rates of transport by EmrE
are observed with mixtures of DOPC and DOPG, rather
than pure DOPG. An overall decrease in MV associated
with lipid vesicles was observed in PG/PE lipid vesicles as
the proportion of PE increased up to 40% but no further
variation was observed above 40% PE.
In spite of the lack of complete saturation (see figure 4),
we estimated Km or Vmax for PC/PG mixtures after taking
more data points up to 600 μM MV (see inset figure 4). No
significant changes could be detected in Km (of ~1 mM) as
the PG mole fraction was altered, but the Vmax increased
with increasing PG, from 2 μmole.min-1 in DOPC, to
around 20 μmole.min-1 in DOPC/DOPG mixtures or
DOPG alone (see table 2). Thus, the presence of PG above
a mole fraction of 0.5 causes an approximate 10-fold
increase in Vmax, but no detectable change in Km. This
shows that the 22-fold increase in initial rate upon addi-
tion of >0.4 mole fraction PG (see figure 2c and table 1) is
reflected in an increase in Vmax.
MV transport data at high MV with PE present in the lipid
vesicles (i.e. DOPC/DOPE or DOPG/DOPE) was too error
prone for analysis and the data did not show the same
trends with PE at high and low MV. The initial rate was
approximately linear with MV, did not saturate and did
not fit to Michaelis Menten kinetics. This suggests signifi-
cant interaction of MV when PE is present and it was not
possible to estimate Km or Vmax values.
Discussion
We have found that lipids have significant influence on
multidrug transport. The addition of DOPE or DOPG to a
DOPC background is able to alter substrate transport by
SMR proteins by over an order of magnitude. A compari-
son of two transporters, EmrE and TBsmr, from bacteria
with dissimilar native lipid compositions, reveals com-
monalities in their lipid dependences.
Lipid dependences of the SMR family of proteins
The native membranes of EmrE and TBsmr are of similar
composition with PE lipids being the majority constituent
closely followed by an anionic lipid. The most abundant
anionic lipids in EmrE native membranes are PG lipids
opposed to PI lipids found in native TBsmr membranes.
The initial rate of MV transport at low MV concentrations
Initial transport rate as a function of 14C MV2+ concentration i  DOPCFigure 4
Initial transport rate as a function of 14C MV2+ con-
centration in DOPC. Inset: data over 600 μM 14C MV2+ 
for transport in (n), DOPC; (r) DOPG and (t) DOPC/
DOPG with 0.7 mole fraction DOPG. Curves represent fits 
of the data to the Michaelis Menten equation.Page 7 of 12
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ences of the two protein activities. MV uptake has been
previously used to determine EmrE function and initial
rate values ranging between 160 to 30,000 nmol.min-
1.mg-1 have been reported for EmrE reconstituted into E.
coli vesicles[7,8,26,27]. The diverse values are attributed
to variations in reconstitution methodologies, solubilisa-
tion conditions and lipid concentrations. Our initial rate
values (of 250 nmol.min-1.mg-1 for EmrE in E. coli) are in
agreement with the lower end of this range of values. In
vivo experiments have been utilised to identify SMR lig-
ands [7,8] but limited kinetic characterisation has been
undertaken. Here, we have investigated how varying lipid
compositions, which mimic aspects of the in vivo environ-
ments, affect SMR transport in vitro.
The incorporation of PE into PC bilayers increases the ini-
tial rate of MV transport for both EmrE and TBsmr up to
0.4 PE mole fraction (see figures 2c and 3b). TBsmr is less
active in DOPC lipid vesicles than EmrE and shows a
smaller, 4-fold increase in transport rate with PE, com-
pared to 20-fold for EmrE. Both proteins also showed rate
increases when DOPG was added to DOPC; about 25-fold
for EmrE and 5-fold for TBsmr. TBsmr showed a larger,
20-fold, increase in rate when its native PI lipid head-
group was added instead of DOPG (figure 3c). These
results show that a fluid DOPC lipid bilayer structure
imparts a degree of transport activity to SMR proteins.
However, transport is suboptimal in DOPC and regardless
of the lipid added to DOPC, an increase in transport rate
is observed when the DOPC mole fractions falls below 0.6
(see figures 2c,d and 3b,c). This implies a threshold level
of PC of ~0.6 mole fraction in binary lipid mixtures,
above which transport is hindered. An increase in rate
occurs upon addition of PE or an anionic lipid to PC. A
faster transport rate still is seen in the absence of PC, but
with a combination of PE and the anionic lipid. These are
the dominant lipid types in the native membranes: PG/PE
for EmrE and PI/PE for TBsmr, which give ~70-fold and
25-fold increases in initial rate over that in DOPC (which
is not present in either native membrane). In this study,
synthetic lipids with defined chain compositions were
used rather than the mixtures of differing chain length
and saturation present in native lipid compositions, thus
these varying natural chains could also further enhance
transport activity. The data for EmrE in PC/PG (figure 4)
show that the increase is due to PG increasing the maxi-
mum transport rate, Vmax. The negative charge of PG or PI
is likely to play a role in attracting the positively charged
MV substrate. The larger increase in transport observed
with PI over PG for TBsmr, presumably reflects a preferen-
tial interaction with its native inositol group.
Lipid effects on membrane proteins
Membrane proteins are heavily influenced by their sur-
rounding lipid environment. Specific lipid interactions
have been identified with lipids either being seen tightly
bound in X-ray structures or a certain lipid being essential
for function [33]. Alternatively, generic bilayer properties
can significantly influence protein function [23]. Key
properties include a mis-match between the hydrophobic
length of the protein and lipid bilayer as well as the elastic
properties of the bilayer, which include curvature energy
and lateral pressure. Thus, alamethicin channel formation
and function has been directly linked to bilayer curvature
in PC/PE bilayers [21,22], folding is also dependent on
this curvature and lateral pressure in PC/PE systems [20].
Here we have shown that PE favours EmrE or TBsmr trans-
port activity, in an anionic lipid background (PG for EmrE
or PI for TBsmr). Although, the greatest influence on
transport is the anionic lipid.
Lipids have also previously been shown to affect transport
function but it is only recently that systematic studies have
been undertaken to investigate their effect on integral
membrane proteins. E. coli lactose permease is known to
be affected by lipids [34], with initial rates of lactose
showing similar dependences on PE as reported here for
SMR proteins. The lactose rate increased upon addition of
0.5 mole fraction PE to PC. The effect of PG differed to
that reported here, as 0.5 mole fraction PG did not
increase the lactose rate, unlike the large 20-fold increase
seen here for EmrE. PE has also been reported to affect the
biogenesis, folding and topology of lactose permease and
other transporters [35-37]. Other multidrug transporters
of the major facilitator superfamily (MFS) including
GabP, PheP and LmrP [38-40] have shown lipid depend-
encies for function. In the case of LmrP the replacement of
PE for PC in the bilayer lead to significant alterations in
both structure and function. Further studies on LmrP
Table 2: Vmax and Km for EmrE in DOPC/DOPG liposomes
Mole fraction of DOPG added to DOPC Vmax (μmole.min-1) Km (mM)
0 2 ± 2 1.1 ± 0.5
0.5 20 ± 2 0.9 ± 0.5
0.7 24 ± 6 1.0 ± 0.4
1 19 ± 6 1.2 ± 0.8
Errors are the standard deviation of the fit of the data to the Michaelis Menten curve)Page 8 of 12
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tions between the PE headgroup and certain LmrP amino
acids are directly involved in pH sensing required for sub-
strate transport [41]. There are also some indications that
multidrug transporters from other protein families are
also dependent on lipid composition. In the case of the
ATP binding cassette multidrug transporter, p-glycopro-
tein, drug binding has also been shown to be influenced
by lipid environment [42].
Conclusion
The data presented here highlight the importance of
investigating the influence of the lipid environment on
SMR protein activity. The addition of PE to PC bilayers has
the same effect on both EmrE and TBsmr activity demon-
strating that the lipid environment of homologous pro-
teins affects their activity in the same manner. Overall,
these data show that the use of sub-optimal lipid compo-
sitions can have a large effect on the transport kinetics and
relative substrate affinities obtained during in vitro study
of multidrug transport.
Methods
Lipids were from Avanti Polar Lipids Inc.: DOPC, DOPG,
DOPE, E. coli or soyPI, where the first three are pure syn-
thetic lipids (with two C18 chains each with one unsatu-
rated bond), and the last two are natural lipid extracts,
containing a mixture of lipid chains lengths and satura-
tion. E. coli lipids also contain a range of headgroups.
Detergents DDM and OG were from Anatrace; anti c Myc
alkaline phosphatase from Sigma-Aldrich; Ni-NTA agar-
ose from QIAGEN, carboxyfluorescein from Molecular
Probes and all other compounds were obtained from
Sigma-Aldrich.
Protein preparation
EmrE-His and TBsmr-His were cloned into pT7-7, trans-
formed into E. coli TA15/pGP1-3 and overexpression
(induced by heat shock) and purification were performed
as previously described [3,5]. A 6 L volume of cells was
disrupted by passage through a French ™pressure cell at
1000 psi (6900 kPa). Isolated membranes were solubi-
lised at 4°C for at least 2 hours in 50 ml of solubilising
buffer (20 mM Tris, pH 7.5, 100 mM NaCl, 10 mM 2-mer-
captoethanol, and 1% (w/v) DDM). Insoluble material
was removed by centrifugation at 35 000 g and 4°C. NaCl
and imidazole were added to final concentrations of 350
mM and 15 mM respectively, and DDM solubilised pro-
tein was consequently incubated with 1.5 ml of Ni-NTA
agarose (QIAGEN) for 1.5 h at 4°C. Non-specifically
bound protein was removed by washing with 30 column
volumes of 20 mM Tris pH 7.5, 400 mM NaCl, 15 mM
imidazole, 0.1% DDM and 5 mM 2-mercaptoethanol, fol-
lowed by 15 column volumes of the above buffer with the
exception of 20 mM NaCl. Proteins were eluted with 5
column volumes of elution buffer (20 mM Tris, pH 7.5,
25 mM NaCl, 200 mM imidazole, 0.1% DDM and 5 mM
2-mercaptoethanol). Eluted protein was concentrated in
an Amicon Ultra 50 000 MWCO centrifugal concentrator
(Millipore) to approximately 1–2 mM as determined by
A280, snap frozen in liquid N2 and stored at -80°C until
required. Protein purity was determined by SDS-PAGE
and Western blot analysis. His-tagged protein was used
throughout. EmrE purified into DDM was assayed for
activity by TPP binding, by radiolabelled TPP binding
curves as well as isothermal titration calorimetry. The lat-
ter gave a dissociation constant, Kd of 36 nM in 0.08%
DDM with a binding stoichiometry of 0.48 TPP per EmrE,
i.e. binding to dimer EmrE, with > 90% of the protein
being active.
Lipid vesicles
Lipid vesicles were prepared with 50 nm, 100 nm or 200
nm diameter by extrusion as previously [43,44]. Vesicles
were also prepared by sonication.
Transport assay
Transport assays were performed as previously described
[8] using radiolabelled 14C MV2+ (Sigma-Aldrich)
(referred to as MV throughout). Protein was first
exchanged from DDM into OG [28]: DDM-protein was
incubated with 1.5 ml of Ni-NTA beads (pre-washed 1%
OG and 20 mM Tris pH 7.5) for 1.5 h at 4°C; loaded onto
a Pharmacia XK-16/20 glass column; washed 4-times with
buffer containing 150 mM NaCl, 1% OG, 15 mM mercap-
toethanol and 15 mM Tris pH 7.5 and then mixed with
elution buffer (the previous buffer with 200 mM imida-
zole and 15 mM mercaptoethanol) and incubated at
room temperature for 15 min. Eluted protein was concen-
trated by centrifugation at 4000 g using Amicon Ultra 50
000 MWCO centrifugal concentrator (Millipore). Protein
in OG was immediately reconstituted into lipid vesicles
(at a starting protein:lipid mole ratio of ~2900:1). Lipids
were rehydrated (to 50 mg.ml-1 in 150 mM NaCl, 15 mM
Tris, pH 7.5) and sonicated or extruded to 50 nm, 100 nm
or 200 nm as stated in the text. The vesicles were mixed
with OG to a final concentration of 0.65% w/v, or a 25:1
molar ratio of lipid to OG. 75 μg of OG solubilised EmrE-
His was added to 375 μl of these OG-lipid vesicles and OG
was removed by a ~70 fold dilution into 25 ml of 190 mM
NH4Cl, 15 mM Tris pH 7.5 followed by mixing at room
temperature for 20 min. The protein-containing vesicles
were centrifuged at 250 000 g for 60 min, at 25°C and the
pellet resuspended in 100 μl of reconstitution buffer (190
mM NH4Cl, 15 mM Tris pH 7.5) and stored at -80°C. Pro-
tein-containing vesicles were thawed, resealed by a 20 s
sonication step and transport was initiated by dilution of
3 μl of protein-containing vesicles into 200 μl of assay
buffer (140 mM KCl, 5 mM MgCl2 and 10 mM Tricine)
containing 42 μM 14C MV2+, at pH 8 for EmrE and pH 9Page 9 of 12
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the reaction was stopped by dilution with 2 ml of ice cold
assay buffer and protein-containing lipid vesicles were
collected by filtration through Scheicher and Schull (0.2
μm) (Millipore, Watford, UK) filters. (Although the pro-
cedure commenced with extruded unilamellar vesicles,
their size will have altered during reconstitution and the
transport assay. We found, as previously reported [8], that
0.2 μm filters worked well and better than smaller pore
sizes). Filters were placed into scintillation vials with 10
ml of Emulsifier-safe scintillation fluid (PerkinElmer) and
radioactivity was measured in a TRI-CARB 2100TR Liquid
Scintillation Counter. Experiments were carried out in
triplicates.
The amount of OG and DDM remaining after reconstitu-
tion was determined by a phenol sulphuric acid carbohy-
drate assay [45]. For this assay, 50 μl of the protein-
containing vesicles were added to 250 μl of 5% (w/v) phe-
nol and 600 μl of concentrated sulphuric acid. This mix-
tures was incubated for 5 min and the absorbance was
measured at 460 nm.
Maintenance of pH was monitored by incorporation of
the pH sensitive dye carboxyfluorescein (Molecular
Probes) inside protein-containing lipid vesicles. Protein-
containing vesicles were formed as described above in the
presence of 10 μM carboxyfluoroscein. 3 μl of protein-
containing vesicles were diluted into 200 μl of assay buffer
and thoroughly mixed by pipetting. Changes in carboxy-
fluoroscein fluorescence were monitored over 15 min, at
25°C by exciting the sample at 475 nm and measuring
emission at 520 nm.
Initial transport rates of MV were determined from the
gradient of the linear part of the MV accumulation versus
time (e.g. figure 1a): over ~the first 6 mins for EmrE or 16
mins for TBsmr. Rates (apart from those for Km and Vmax
determinations) were determined for 42 μM MV. All fit-
ting was carried out using MicroCal Origin 6.0 software.
Initial rates were calculated per mg of protein associated
with lipid vesicles after reconstitution. Note that identical
protein samples were used for each lipid series; protein
aliquots were taken from the same protein sample
exchanged from DDM into OG for all DOPC/DOPE
measurements, or all from a separate protein sample for
all DOPC/DOPG or DOPG/DOPE measurements.
The amount of protein was quantified on samples after
the transport assay, on the same sample, from colorimet-
ric development of Western blots [46], by densitometry
using Quantity One® software (BioRad). The actual
amount of reconstituted protein was calculated by com-
paring band densities between protein-containing lipid
vesicle samples, normalised to an aliquot of the same pro-
tein preparation which had been previously quantified
(each Western always contained a band from a protein
sample that had already been quantified on another gel,
to enable normalising between gels). Protein-containing
vesicle samples were run on 10% SDS denaturing gels and
transferred to polyvinyl difluoride membranes prior to
incubation with anti c Myc alkaline phosphatase (1:5000)
(Sigma Aldrich) (the protein constructs contained a Myc
epitope). Alkaline phosphate substrate solution, BCIP-
NBT (Sigma Aldrich), was applied to the membrane as per
manufacturer's protocol for protein visualisation and
quantification. The BCIP-NBT detection system is based
on the hydrolysis of 5-bromo-4-chloro-3 indolyl phos-
phate (BCIP) and the reduction of p-nitrobluetetrazolium
chloride (NBT) producing a purple product, which can be
colorimetrcally quantified. This Western blot method due
to its high sensititivity (0.5 ng of substrate) [47,48]proved
effective for quantifying the relatively small amounts of
EmrE reconstituted by the method here, which was opti-
mised to maintain a pH gradient rather than to optimise
EmrE concentrations. The amount of reconstituted pro-
tein was also assessed by a modified Lowry method as
well as following solvent extraction of protein and lipid.
For the latter EmrE samples in lipid were solubilised using
a 43:43:14 chloroform:methanol:sample (v/v) ratio and
absorbance spectrum measured between 250 and 310
nm. EmrE standards of known concentration in DDM
were used for calibration and lipid samples in the absence
of EmrE were used to subtract any non-protein absorb-
ance in the region from 250–310 nm.
In order to determine Km and Vmax MV transport assays
were performed with different concentrations of 14C MV
at three different lipid mole fractions for each lipid series:
DOPC/DOPE, DOPC/DOPG and DOPC/DOPG. MV
concentrations were between 5 μM and 2 mM MV (spiked
with 5% 14C MV2+). The extent of non-specific binding of
MV was determined in control experiments in protein-free
lipid vesicles (for all lipid compositions). This non-spe-
cific binding was corrected for in the binding curves
shown. At 42 μM MV this background binding was signif-
icantly lower than the specific binding and transport. 42
μM MV corresponds to: ~250:1 mole ratio MV to protein
and ~50:1 lipid: MV; 600 μM MV to: ~4000:1 MV to pro-
tein, and 3:1 lipid: MV.
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